These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23098258)

  • 41. [Analysis of risk factors of ventilator-associated pneumonia in an intensive care unit].
    Wang J; Li DX; Yu CX; Huang S; Liang YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):719-23. PubMed ID: 27222193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia].
    Karaboğa B; Çilli A
    Tuberk Toraks; 2015 Jun; 63(2):94-101. PubMed ID: 26167966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Features of severe pneumonia in patients with undiagnosed pulmonary tuberculosis in an intensive care unit.
    Hui C; Wu CL; Chan MC; Kuo IT; Chiang CD
    J Formos Med Assoc; 2003 Aug; 102(8):563-9. PubMed ID: 14569322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study.
    Brereton CJ; Lennon D; Browning S; Dunn E; Ferguson JK; Davis JS
    Int J Antimicrob Agents; 2018 Jun; 51(6):862-866. PubMed ID: 29410326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic treatment strategies for community-acquired pneumonia in adults.
    Postma DF; van Werkhoven CH; van Elden LJ; Thijsen SF; Hoepelman AI; Kluytmans JA; Boersma WG; Compaijen CJ; van der Wall E; Prins JM; Oosterheert JJ; Bonten MJ;
    N Engl J Med; 2015 Apr; 372(14):1312-23. PubMed ID: 25830421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Performance of clinical pulmonary infection score induces the duration and defined daily doses of antibiotics in patients with bacterial severe pneumonia in intensive care unit].
    Shen F; Wu Y; Wang Y; Li W; Liu B; Qian H; Yang H; Yang G; Li X; Zheng X; Wu Y; Xie L; Gao D; Li L; Liu M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):556-561. PubMed ID: 31198139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy.
    Lautenbach E; Metlay JP; Bilker WB; Edelstein PH; Fishman NO
    Clin Infect Dis; 2005 Oct; 41(7):923-9. PubMed ID: 16142655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis.
    Chen TC; Lu PL; Lin CY; Lin WR; Chen YH
    Int J Infect Dis; 2011 Mar; 15(3):e211-6. PubMed ID: 21195001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care.
    Erbes R; Oettel K; Raffenberg M; Mauch H; Schmidt-Ioanas M; Lode H
    Eur Respir J; 2006 Jun; 27(6):1223-8. PubMed ID: 16481385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study.
    Wang JY; Lee CH; Yu MC; Lee MC; Lee LN; Wang JT
    Eur Respir J; 2015 Aug; 46(2):567-70. PubMed ID: 25900374
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.
    Wilson BZ; Anzueto A; Restrepo MI; Pugh MJ; Mortensen EM
    Crit Care Med; 2012 Aug; 40(8):2310-4. PubMed ID: 22622401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mortality prediction in community-acquired pneumonia requiring mechanical ventilation; values of pneumonia and intensive care unit severity scores.
    Aydoğdu M; Ozyilmaz E; Aksoy H; Gürsel G; Ekim N
    Tuberk Toraks; 2010; 58(1):25-34. PubMed ID: 20517726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems.
    Jabeen K; Shakoor S; Hasan R
    Int J Infect Dis; 2015 Mar; 32():118-23. PubMed ID: 25809767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic treatment outcomes in community-acquired pneumonia.
    Çilli A; Sayıner A; Çelenk B; Şakar Coşkun A; Kılınç O; Hazar A; Aktaş Samur A; Taşbakan S; Waterer GW; Havlucu Y; Kılıç Ö; Tokgöz F; Bilge U
    Turk J Med Sci; 2018 Aug; 48(4):730-736. PubMed ID: 30119147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoroquinolones for the treatment of pulmonary tuberculosis.
    Moadebi S; Harder CK; Fitzgerald MJ; Elwood KR; Marra F
    Drugs; 2007; 67(14):2077-99. PubMed ID: 17883288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Appropriateness of empirical antibiotics: risk factors of adult patients with sepsis in the ICU.
    Al-Sunaidar KA; Prof Abd Aziz N; Prof Hassan Y
    Int J Clin Pharm; 2020 Apr; 42(2):527-538. PubMed ID: 32144611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS.
    Rahmel T; Asmussen S; Karlik J; Steinmann J; Adamzik M; Peters J
    BMC Anesthesiol; 2017 Jun; 17(1):78. PubMed ID: 28615012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pulmonary tuberculosis mimicking a severe community-acquired pneumonia with rhabdomyolysis].
    Tedesco A; Guglielmetti L; Conti M; Cazzadori A; Concia E
    Infez Med; 2013 Jun; 21(2):146-8. PubMed ID: 23774981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment.
    Jeong BH; Jeon K; Park HY; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Huh HJ; Lee NY; Koh WJ
    J Antimicrob Chemother; 2015 Nov; 70(11):3127-33. PubMed ID: 26203184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.